Medtronic secures approval to buy Covidien after agreeing to divestitures
Medical device maker Medtronic Inc. resolved the Competition Bureau’s concern that its acquisition of competitor Covidien PLC would reduce competition for the supply of drug-coated balloon catheters for the treatment of peripheral artery disease by agreeing to sell Covidien’s drug-coated balloon catheter business to Spectanetics. Medtronic and Covidien signed a consent agreement with the Bureau. [more] Full article
Reliance acquires its largest competitor, National
Shortly after agreeing to pay hefty $5 million penalty to settle the Competition Bureau’s allegations that it engaged in anti-competitive tactics to prevent competitors from expanding, hot water heater supplier ... [more] Full article
Manulife – Standard Life Acquisition Cleared
Insurance giant Manulife Financial Corporation’s proposed acquisition of Standard Life PLC’s Canadian assets has been approved by the Competition Bureau. Both companies offer group retirement and benefits services and individual wealth products, ... [more] Full article
Green light for Transforce’s Acquisition of Contrans
Trucking company Transforce got a green light from the Competition Bureau to complete its acquisition of its rival Contrans. Both companies provide non-specialized (dry box trailers) and specialized trucking services. The ... [more] Full article